论文部分内容阅读
金融风暴影响全球经济,制药行业这次也未能幸免。对于新兴市场中国和印度来讲,危机中处处显现商机。跨国公司比以往更需要削减成本,提高效率,必须把许多研发和生产性任务外包到亚洲
The financial crisis affected the global economy and the pharmaceutical industry was not spared this time. For emerging markets such as China and India, there are opportunities in the crisis. MNCs need to cut costs and improve efficiency more than ever before and must outsource many R & D and production tasks to Asia